On August 11, 2026, Eric Foster notified Ardelyx, Inc. of his decision to resign as Chief Commercial Officer, effective August 28, 2026. Mr. Foster resigned to pursue a new opportunity with a pre-commercial company, and the resignation is not due to any disagreement with the Company. Ardelyx, Inc. operates in the pharmaceutical industry, developing therapies for gastrointestinal diseases.
